Cancervision is a new paradigm in cancer diagnostics that enables cancer precision medicine with whole genome sequencing (WGS).

 It combines a patient's cancer mutation and genome sequencing information with precision reading technology to facilitate cancer diagnosis and treatment for healthcare providers. Cancervision quickly and accurately detects genetic alterations such as point mutations, structural changes and gene fusions associated with FDA-approved drugs.
 
It provides the most complete medical information by sequencing the entire genome at once.  Simple to complex structural variants in genes can be analyzed, and even unknown variants can be detected. Genomic discoveries can help guide personalized treatment approaches, improve decision making, and inform clinical research. In the clinic, whole genome testing helps address the problem of incomplete data from NGS panel tests, which leads to unnecessary additional testing, time and cost.
 
Canvision, which can analyze WGS at low cost, will be a powerful tool in cancer diagnosis and treatment.